vs
Cosmos Health Inc.（COSM）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
Cosmos Health Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.5倍（$19.7M vs $13.2M），Cosmos Health Inc.净利率更高（-51.5% vs -73.9%，领先22.4%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 38.5%），TriSalus Life Sciences, Inc.自由现金流更多（$-2.5M vs $-4.6M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs 16.2%）
阿格尼库尔宇宙私人有限公司是总部位于金奈印度理工学院燃烧研究与开发国家中心的印度民营航空航天制造商及商业发射服务提供商。这家初创企业致力于开发并发射自主小型运载火箭，其中代表性的阿格尼班火箭可将100公斤有效载荷送入700公里轨道。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
COSM vs TLSI — 直观对比
营收规模更大
COSM
是对方的1.5倍
$13.2M
营收增速更快
TLSI
高出21.3%
38.5%
净利率更高
COSM
高出22.4%
-73.9%
自由现金流更多
TLSI
多$2.1M
$-4.6M
两年增速更快
TLSI
近两年复合增速
16.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.7M | $13.2M |
| 净利润 | $-10.1M | $-9.8M |
| 毛利率 | 10.6% | 86.7% |
| 营业利润率 | -57.9% | -24.8% |
| 净利率 | -51.5% | -73.9% |
| 营收同比 | 38.5% | 59.8% |
| 净利润同比 | -203.0% | 3.5% |
| 每股收益（稀释后） | $-0.33 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COSMTLSI
| Q4 25 | $19.7M | $13.2M | ||
| Q3 25 | $17.1M | $11.6M | ||
| Q2 25 | $14.7M | $11.2M | ||
| Q1 25 | $13.7M | $9.2M | ||
| Q4 24 | $14.2M | $8.3M | ||
| Q3 24 | $12.4M | $7.3M | ||
| Q2 24 | $13.2M | $7.4M | ||
| Q1 24 | $14.6M | $6.5M |
净利润COSMTLSI
| Q4 25 | $-10.1M | $-9.8M | ||
| Q3 25 | $-5.4M | $-10.8M | ||
| Q2 25 | $-2.8M | $-8.3M | ||
| Q1 25 | $-818.1K | $-10.4M | ||
| Q4 24 | $-3.3M | $-10.1M | ||
| Q3 24 | $-8.4M | $-2.4M | ||
| Q2 24 | $-2.6M | $-4.3M | ||
| Q1 24 | $-1.9M | $-13.2M |
毛利率COSMTLSI
| Q4 25 | 10.6% | 86.7% | ||
| Q3 25 | 15.2% | 83.5% | ||
| Q2 25 | 7.9% | 83.9% | ||
| Q1 25 | 14.9% | 83.7% | ||
| Q4 24 | 7.1% | 85.3% | ||
| Q3 24 | 9.7% | 86.3% | ||
| Q2 24 | 5.8% | 87.6% | ||
| Q1 24 | 9.1% | 85.0% |
营业利润率COSMTLSI
| Q4 25 | -57.9% | -24.8% | ||
| Q3 25 | -10.6% | -77.9% | ||
| Q2 25 | -17.9% | -65.4% | ||
| Q1 25 | -6.1% | -79.9% | ||
| Q4 24 | -63.0% | -91.8% | ||
| Q3 24 | -18.0% | -118.9% | ||
| Q2 24 | -18.9% | -111.0% | ||
| Q1 24 | -12.6% | -180.8% |
净利率COSMTLSI
| Q4 25 | -51.5% | -73.9% | ||
| Q3 25 | -31.3% | -93.5% | ||
| Q2 25 | -19.2% | -73.9% | ||
| Q1 25 | -6.0% | -113.2% | ||
| Q4 24 | -23.5% | -122.4% | ||
| Q3 24 | -67.5% | -32.6% | ||
| Q2 24 | -19.6% | -58.8% | ||
| Q1 24 | -12.8% | -204.5% |
每股收益（稀释后）COSMTLSI
| Q4 25 | $-0.33 | $-0.22 | ||
| Q3 25 | $-0.17 | $-0.96 | ||
| Q2 25 | $-0.10 | $-0.27 | ||
| Q1 25 | $-0.03 | $-0.39 | ||
| Q4 24 | $-0.46 | $-0.38 | ||
| Q3 24 | $-0.45 | $-0.12 | ||
| Q2 24 | $-0.15 | $-0.21 | ||
| Q1 24 | $-0.11 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $761.8K | $20.4M |
| 总债务越低越好 | $3.8M | — |
| 股东权益账面价值 | $18.4M | $-33.9M |
| 总资产 | $65.5M | $35.3M |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势，按日历期对齐
现金及短期投资COSMTLSI
| Q4 25 | $761.8K | $20.4M | ||
| Q3 25 | $922.6K | $22.7M | ||
| Q2 25 | $30.3K | $26.5M | ||
| Q1 25 | $25.3K | $13.0M | ||
| Q4 24 | $336.3K | $8.5M | ||
| Q3 24 | $22.8K | $11.3M | ||
| Q2 24 | $21.5K | $16.5M | ||
| Q1 24 | $21.3K | $4.0M |
总债务COSMTLSI
| Q4 25 | $3.8M | — | ||
| Q3 25 | $5.4M | — | ||
| Q2 25 | $5.2M | — | ||
| Q1 25 | $4.9M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $4.3M | — | ||
| Q2 24 | $3.9M | — | ||
| Q1 24 | $4.1M | — |
股东权益COSMTLSI
| Q4 25 | $18.4M | $-33.9M | ||
| Q3 25 | $23.1M | $-26.7M | ||
| Q2 25 | $26.2M | $-19.4M | ||
| Q1 25 | $26.0M | $-34.4M | ||
| Q4 24 | $24.5M | $-25.9M | ||
| Q3 24 | $35.0M | $-20.4M | ||
| Q2 24 | $32.1M | $-25.3M | ||
| Q1 24 | $34.5M | $-36.0M |
总资产COSMTLSI
| Q4 25 | $65.5M | $35.3M | ||
| Q3 25 | $69.5M | $36.5M | ||
| Q2 25 | $61.8M | $41.3M | ||
| Q1 25 | $57.2M | $28.6M | ||
| Q4 24 | $54.3M | $24.0M | ||
| Q3 24 | $64.5M | $27.5M | ||
| Q2 24 | $60.8M | $32.4M | ||
| Q1 24 | $62.3M | $17.9M |
负债/权益比COSMTLSI
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.19× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.6M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $-4.6M | $-2.5M |
| 自由现金流率自由现金流/营收 | -23.4% | -19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.5M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流COSMTLSI
| Q4 25 | $-4.6M | $-2.5M | ||
| Q3 25 | $-2.5M | $-3.7M | ||
| Q2 25 | $-1.2M | $-7.3M | ||
| Q1 25 | $-186.3K | $-4.5M | ||
| Q4 24 | $-3.8M | $-5.7M | ||
| Q3 24 | $739.8K | $-10.8M | ||
| Q2 24 | $-1.2M | $-13.4M | ||
| Q1 24 | $-3.4M | $-10.9M |
自由现金流COSMTLSI
| Q4 25 | $-4.6M | $-2.5M | ||
| Q3 25 | $-2.5M | $-3.9M | ||
| Q2 25 | $-1.2M | $-7.4M | ||
| Q1 25 | $-198.8K | $-5.3M | ||
| Q4 24 | $-3.9M | $-5.8M | ||
| Q3 24 | $511.0K | $-11.0M | ||
| Q2 24 | $-1.2M | $-13.5M | ||
| Q1 24 | $-3.5M | $-10.9M |
自由现金流率COSMTLSI
| Q4 25 | -23.4% | -19.1% | ||
| Q3 25 | -14.4% | -33.9% | ||
| Q2 25 | -8.4% | -66.1% | ||
| Q1 25 | -1.5% | -57.3% | ||
| Q4 24 | -27.5% | -69.7% | ||
| Q3 24 | 4.1% | -149.9% | ||
| Q2 24 | -9.4% | -183.1% | ||
| Q1 24 | -24.0% | -169.3% |
资本支出强度COSMTLSI
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.1% | 1.9% | ||
| Q2 25 | 0.2% | 0.8% | ||
| Q1 25 | 0.1% | 8.2% | ||
| Q4 24 | 0.5% | 0.6% | ||
| Q3 24 | 1.8% | 2.3% | ||
| Q2 24 | 0.3% | 0.8% | ||
| Q1 24 | 0.6% | 1.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
